49,020 ARS
120
0.24%
Last update Dec 16, 4:56 PM -03
Market closed
Day range
48,660
49,660
Previous close
49,140
Open
49,660
Access this stock data via API
Subscribe
Abbott Laboratories Cedear
49,020.00
120
0.24%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 60.8T 40.1B 43.7B 43.1B
Cost of revenue 27.1T 18.0B 19.1B 18.5B
Gross profit 33.7T 22.1B 24.5B 24.5B
Operating expense
Research & development 4.1T 2.7B 2.9B 2.7B
Selling general and admin 17.0T 10.9B 11.2B 11.3B
Other operating expenses
Operating income 9.9T 6.5B 8.4B 8.4B
Non operating interest income
Income 498.8B 385M 183M 43M
Expense 810.6B 637M 558M 533M
Other income expense 584.4B 438M 319M 276M
Pretax income 10.2T 6.7B 8.3B 8.2B
Tax provision -9.3T 941M 1.4B 1.1B
Net income 19.4T 5.7B 6.9B 7.1B
Basic EPS 15.5 6.6 8.0 8.0
Diluted EPS 15.3 6.5 7.8 7.9
Basic average shares 1.3T 819.4K 822.8K 835.3K
Diluted average shares 1.3T 819.4K 822.8K 835.3K
EBITDA 15.6T 10.6B 12.1B 12.3B
Net income from continuing op. 19.4T 5.7B 6.9B 7.1B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 6 hours 26 minutes

04:33
00:00
11:00
17:00
23:59

Trading Hours (Monday - Friday):

Main market
11:00 - 17:00
All times are displayed in the America/Argentina/Buenos_Aires timezone (-03, UTC-03:00).